tetano
Editor, Senior Moderator
J Immunol
. 2020 Jun 15;ji2000085.
doi: 10.4049/jimmunol.2000085. Online ahead of print.
Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1
S Marina Casalino-Matsuda[SUP] 1 [/SUP], Fei Chen[SUP] 2 [/SUP], Francisco J Gonzalez-Gonzalez[SUP] 2 [/SUP], Aisha Nair[SUP] 2 [/SUP], Sandra Dib[SUP] 2 [/SUP], Alex Yemelyanov[SUP] 2 [/SUP], Khalilah L Gates[SUP] 2 [/SUP], G R Scott Budinger[SUP] 2 3 [/SUP], Greg J Beitel[SUP] 4 [/SUP], Peter H S Sporn[SUP] 2 3 [/SUP]
Affiliations
Abstract
Hypercapnia (HC), elevation of the partial pressure of CO[SUB]2[/SUB] in blood and tissues, is a risk factor for mortality in patients with severe acute and chronic lung diseases. We previously showed that HC inhibits multiple macrophage and neutrophil antimicrobial functions and increases the mortality of bacterial pneumonia in mice. In this study, we show that normoxic HC increases viral replication, lung injury, and mortality in mice infected with influenza A virus (IAV). Elevated CO[SUB]2[/SUB] increased IAV replication and inhibited antiviral gene and protein expression in macrophages in vivo and in vitro. HC potentiated IAV-induced activation of Akt, whereas specific pharmacologic inhibition or short hairpin RNA knockdown of Akt1 in alveolar macrophages blocked HC's effects on IAV growth and the macrophage antiviral response. Our findings suggest that targeting Akt1 or the downstream pathways through which elevated CO[SUB]2[/SUB] signals could enhance macrophage antiviral host defense and improve clinical outcomes in hypercapnic patients with advanced lung disease.
. 2020 Jun 15;ji2000085.
doi: 10.4049/jimmunol.2000085. Online ahead of print.
Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1
S Marina Casalino-Matsuda[SUP] 1 [/SUP], Fei Chen[SUP] 2 [/SUP], Francisco J Gonzalez-Gonzalez[SUP] 2 [/SUP], Aisha Nair[SUP] 2 [/SUP], Sandra Dib[SUP] 2 [/SUP], Alex Yemelyanov[SUP] 2 [/SUP], Khalilah L Gates[SUP] 2 [/SUP], G R Scott Budinger[SUP] 2 3 [/SUP], Greg J Beitel[SUP] 4 [/SUP], Peter H S Sporn[SUP] 2 3 [/SUP]
Affiliations
- PMID: 32540997
- DOI: 10.4049/jimmunol.2000085
Abstract
Hypercapnia (HC), elevation of the partial pressure of CO[SUB]2[/SUB] in blood and tissues, is a risk factor for mortality in patients with severe acute and chronic lung diseases. We previously showed that HC inhibits multiple macrophage and neutrophil antimicrobial functions and increases the mortality of bacterial pneumonia in mice. In this study, we show that normoxic HC increases viral replication, lung injury, and mortality in mice infected with influenza A virus (IAV). Elevated CO[SUB]2[/SUB] increased IAV replication and inhibited antiviral gene and protein expression in macrophages in vivo and in vitro. HC potentiated IAV-induced activation of Akt, whereas specific pharmacologic inhibition or short hairpin RNA knockdown of Akt1 in alveolar macrophages blocked HC's effects on IAV growth and the macrophage antiviral response. Our findings suggest that targeting Akt1 or the downstream pathways through which elevated CO[SUB]2[/SUB] signals could enhance macrophage antiviral host defense and improve clinical outcomes in hypercapnic patients with advanced lung disease.